MYCOPLASMA pneumoniae infection in children may lead to plastic bronchitis, with new predictors aiding early detection.
Mycoplasma Pneumoniae Drives Plastic Bronchitis Risk
Mycoplasma pneumoniae infection has increasingly been linked to complications such as plastic bronchitis in children, prompting closer investigation into early predictors. This study evaluated pediatric cases to better understand the factors associated with the development of mycoplasma-associated plastic bronchitis, a severe airway condition characterized by the formation of obstructive bronchial casts.
Among 126 cases of plastic bronchitis analyzed, the majority were associated with mycoplasma infection. Other pathogens were also identified, including rhinovirus, Streptococcus pneumoniae, Hemophilus influenzae, adenovirus, bocavirus, Moraxella catarrhalis, Staphylococcus aureus, and influenza viruses. However, mycoplasma remained the dominant pathogen, reinforcing its central role in disease progression.
Predictive Factors for Mycoplasma-Associated Plastic Bronchitis
The study compared 32 cases of mycoplasma-associated plastic bronchitis with 60 cases of non-plastic bronchitis mycoplasma pneumonia. Statistical analysis identified two independent predictors of plastic bronchitis development: duration of fever and the neutrophil to lymphocyte ratio.
Longer fever duration was significantly associated with increased risk, suggesting that persistent inflammatory response may contribute to disease severity. Similarly, a higher neutrophil to lymphocyte ratio, a marker of systemic inflammation, was linked to the occurrence of plastic bronchitis. These findings highlight the potential value of routine clinical parameters in identifying high risk patients early in the disease course.
Clinical Implications and Treatment Challenges
The findings underscore the importance of early recognition and intervention in children with mycoplasma pneumoniae infection. Plastic bronchitis can lead to significant airway obstruction and requires timely diagnosis to prevent complications.
The study also notes that most cases were resistant to macrolide antibiotics, raising concerns about treatment limitations and the need for alternative therapeutic strategies. Given the presence of multiple co-infecting pathogens in some cases, clinicians may need to consider broader diagnostic and management approaches.
Overall, identifying predictive markers such as fever duration and neutrophil to lymphocyte ratio may support earlier diagnosis and more targeted care for children at risk of mycoplasma-associated plastic bronchitis.
Reference
Jiang F et al. Analysis of Predictive Factors for Mycoplasma-associated Plastic Bronchitis in Children. Diagn Microbiol Infect Dis. 2026;117073. DOI: 10.1016/j.diagmicrobio.2025.117073.
Featured Image: sushytska on Adobe Stock.
